Utama › Kanser Paru-paru › Missouri › St. Louis
Kajian klinikal Kanser Paru-paru di St. Louis, MO
39 kajian untuk Kanser Paru-paru sedang mencari peserta di lokasi dalam dan sekitar St. Louis (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
The Vanguard Study: Testing a New Way to Screen for Cancer
Mengambil pesertaSukarelawan sihat dialu-alukan
- Washington University School of Medicine, St Louis
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Mengambil pesertaFasa 3
- Mercy Hospital South, St Louis
- Cancer Care Center of O'Fallon, O'Fallon · 16 mi jauh
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Mengambil pesertaFasa 3
- Washington University School of Medicine, St Louis
- Veteran's Affairs Medical Center - Saint Louis, St Louis
- Mercy Hospital South, St Louis
- dan 7 lagi
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Mengambil pesertaFasa 3
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- Mercy Hospital Saint Louis, St Louis
- dan 1 lagi
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- dan 4 lagi
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 2
- Washington University, School of Medicine, St Louis
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Mengambil pesertaFasa 3
- Mercy Hospital South, St Louis
- Mercy Hospital Saint Louis, St Louis
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Mengambil pesertaFasa 1
- Washington University School of Medicine, St Louis
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Mengambil pesertaFasa 3
- Washington University Center for Advanced Medicine, St Louis
A Study of PHN-012 in Patients With Advanced Solid Tumors
Mengambil pesertaFasa 1
- PHN-012-001 Site, St Louis
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Mengambil pesertaFasa 3
- Washington University School of Medicine - Siteman Cancer Center, St Louis
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Mengambil pesertaFasa 3
- Mercy South - David M Sindelar Cancer Center ( Site 0098), St Louis
- Mercy Research - David C. Pratt Cancer Center ( Site 0006), St Louis
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Mengambil pesertaFasa 2
- Washington University School of Medicine, St Louis
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- Local Institution - 0140, St Louis
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Mengambil pesertaFasa 2/3
- SSM Health Cancer Care - St. Clare, Fenton · 15 mi jauh
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Mengambil pesertaFasa 2/3
- Washington University School of Medicine, St Louis
A Study Evaluating a New Radiation Treatment Workflow (NGDS)
Mengambil peserta
- Siteman Cancer Center Washington University, St Louis
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Mengambil pesertaFasa 1/2
- Washington University, St Louis
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Missouri Baptist Medical Center, St Louis
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Mengambil pesertaKajian pemerhatian
- Washington University School of Medicine, St Louis
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Mengambil pesertaFasa 3
- Washington University School of Medicine, St Louis
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- Mercy Hospital Saint Louis, St Louis
- dan 3 lagi
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Mengambil pesertaFasa 3
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- dan 4 lagi
Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Barnes-Jewish Hospital West County, Creve Coeur · 12 mi jauh
Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital
Mengambil pesertaSukarelawan sihat dialu-alukan
- Barnes-Jewish Christian Hospital, St Louis
IDOV-Immune for Advanced Solid Tumors
Mengambil pesertaFasa 1
- Washington University School of Medicine, St Louis
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Mengambil pesertaFasa 1/2
- Washington University School of Medicine (Siteman Cancer Center), St Louis
CARE Tool Study Aim 3
Mengambil peserta
- Washington University School of Medicine, St Louis
- Alton Memorial Hospital, Alton · 18 mi jauh
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Mengambil pesertaFasa 1/2
- Washington University, St Louis
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Mengambil pesertaFasa 1
- Research Site, St Louis
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- Mercy Hospital Saint Louis, St Louis
- dan 2 lagi
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Mengambil pesertaFasa 1/2
- Washington University Infusion Center Pharmacy, St Louis
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2/3
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- dan 7 lagi
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- dan 4 lagi
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Mengambil pesertaFasa 1/2
- Washington University School of Medicine, St Louis
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Washington University School of Medicine, St Louis
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Mengambil pesertaKajian pemerhatian
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- BJC Outpatient Center at Sunset Hills, Sunset Hills · 13 mi jauh
- dan 3 lagi
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, St Louis
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Mengambil pesertaFasa 1/2
- Washington University, St Louis
Kajian Kanser Paru-paru di bandar lain
- Houston, TX78 kajian
- Boston, MA62 kajian
- New York City, NY60 kajian
- Los Angeles, CA45 kajian
- Arlington, VA41 kajian
- Washington, DC41 kajian
- Chicago, IL41 kajian
- Baltimore, MD40 kajian
- Nashville, TN40 kajian
- Columbus, OH37 kajian
- Philadelphia, PA36 kajian
- Seattle, WA33 kajian
Kajian lain di St. Louis
- Kanser Paru-paru Bukan Sel Kecil73 kajian
- Kanser Payudara64 kajian
- Kanser Metastatik54 kajian
- Kanser Kolorektal50 kajian
- Kanser (semua jenis)46 kajian
- Kanser Prostat46 kajian
- Kanser Ovari38 kajian
- Kanser Pankreas33 kajian
- Kanser Endometrium29 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher28 kajian
- Kegagalan Jantung26 kajian
- Obesiti25 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.